Lupin receives USFDA nod for hypertension treatment drug in US
Drug major Lupin has received tentative approval from the US health regulator to sell Olmesartan medoximil tablets, used for treating high blood pressure, in the American market.
Dec 26, 2016, 11:46 AM IST
Former promoters of Ranbaxy asked to pay Rs 2,600 crore to Daiichi
In a major setback to Malvinder Mohan Singh and Shivinder Mohan Singh, the erstwhile promoters of Ranbaxy Laboratories, the Singapore Court of Arbitration slapped a fine of about Rs 2,600 crore ($400 million) for supressing facts while selling the company to Japanese pharmaceutical company Daiichi Sankyo in 2008
May 05, 2016, 15:44 PM IST
Japan's Daiichi completely exits Sun Pharma
Yesterday, Daiichi Sankyo Company Ltd had announced its decision to sell "the entire or part of its holdings of Sun Pharmaceutical shares..."
Apr 21, 2015, 12:40 PM IST
